The symbiotic relationship between Vital Images and Toshiba Medical Systems will continue under a U.S. and international marketing and distribution agreement that extends Toshiba's right to offer Vital Images' Vitrea 2 software. Toshiba has distributed
The symbiotic relationship between Vital Images and Toshiba Medical Systems will continue under a U.S. and international marketing and distribution agreement that extends Toshiba's right to offer Vital Images' Vitrea 2 software. Toshiba has distributed the software since 2000 through its subsidiaries and distributors in more than 50 nations in North and South America, Europe, the Middle East, Africa, Australia, and Asia, excluding Japan. The 3D medical imaging product is sold primarily as an adjunct to Toshiba's Aquilion and Asteon CT scanners. The new agreement includes a minimum worldwide revenue commitment from Toshiba of $7.7 million and is effective through Dec. 31, 2004. At the RSNA meeting, Vital Images demonstrated Vitrea version 3.4 offering enhanced 3D visualization and analysis tools, including automated tools for examining vasculature.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.